Annual Interest Expense
$13.31 M
+$5.10 M+62.11%
31 December 2023
Summary:
BioXcel Therapeutics annual interest expense is currently $13.31 million, with the most recent change of +$5.10 million (+62.11%) on 31 December 2023. During the last 3 years, it has risen by +$13.29 million (+49211.11%). BTAI annual interest expense is now at all-time high.BTAI Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$3.79 M
+$90.00 K+2.43%
30 September 2024
Summary:
BioXcel Therapeutics quarterly interest expense is currently $3.79 million, with the most recent change of +$90.00 thousand (+2.43%) on 30 September 2024. Over the past year, it has increased by +$538.00 thousand (+16.54%). BTAI quarterly interest expense is now at all-time high.BTAI Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$14.53 M
+$538.00 K+3.84%
30 September 2024
Summary:
BioXcel Therapeutics TTM interest expense is currently $14.53 million, with the most recent change of +$538.00 thousand (+3.84%) on 30 September 2024. Over the past year, it has increased by +$1.73 million (+13.55%). BTAI TTM interest expense is now at all-time high.BTAI TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTAI Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.1% | +16.5% | +13.6% |
| 3 y3 years | +10000.0% | - | - |
| 5 y5 years | - | +10000.0% | +10000.0% |
BTAI Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5 years | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | at high | >+9999.0% | at high | >+9999.0% |
BioXcel Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.79 M(+2.4%) | $14.53 M(+3.8%) |
| June 2024 | - | $3.70 M(+2.6%) | $13.99 M(+3.3%) |
| Mar 2024 | - | $3.61 M(+5.0%) | $13.55 M(+1.8%) |
| Dec 2023 | $13.31 M(+62.1%) | $3.44 M(+5.6%) | $13.31 M(+4.0%) |
| Sept 2023 | - | $3.25 M(-0.2%) | $12.80 M(-3.4%) |
| June 2023 | - | $3.26 M(-3.2%) | $13.25 M(+14.5%) |
| Mar 2023 | - | $3.37 M(+15.3%) | $11.57 M(+40.9%) |
| Dec 2022 | $8.21 M | $2.92 M(-21.1%) | $8.21 M(+55.2%) |
| Sept 2022 | - | $3.70 M(+133.3%) | $5.29 M(+232.3%) |
| June 2022 | - | $1.59 M(>+9900.0%) | $1.59 M(+6826.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $7000.00(-56.3%) | $23.00 K(-28.1%) |
| Dec 2021 | $40.00 K(+48.1%) | - | - |
| June 2021 | - | $16.00 K(+128.6%) | $32.00 K(+14.3%) |
| Mar 2021 | - | $7000.00(+75.0%) | $28.00 K(+3.7%) |
| Dec 2020 | $27.00 K(+35.0%) | $4000.00(-20.0%) | $27.00 K(-775.0%) |
| Sept 2020 | - | $5000.00(-58.3%) | -$4000.00(-144.4%) |
| June 2020 | - | $12.00 K(+100.0%) | $9000.00(-400.0%) |
| Mar 2020 | - | $6000.00(-122.2%) | -$3000.00(-66.7%) |
| Dec 2019 | $20.00 K(>+9900.0%) | -$27.00 K(-250.0%) | -$9000.00(-150.0%) |
| Sept 2019 | - | $18.00 K | $18.00 K |
| Dec 2016 | $0.00 | - | - |
FAQ
- What is BioXcel Therapeutics annual interest expense?
- What is the all time high annual interest expense for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual interest expense year-on-year change?
- What is BioXcel Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly interest expense year-on-year change?
- What is BioXcel Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for BioXcel Therapeutics?
- What is BioXcel Therapeutics TTM interest expense year-on-year change?
What is BioXcel Therapeutics annual interest expense?
The current annual interest expense of BTAI is $13.31 M
What is the all time high annual interest expense for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual interest expense is $13.31 M
What is BioXcel Therapeutics annual interest expense year-on-year change?
Over the past year, BTAI annual interest expense has changed by +$5.10 M (+62.11%)
What is BioXcel Therapeutics quarterly interest expense?
The current quarterly interest expense of BTAI is $3.79 M
What is the all time high quarterly interest expense for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly interest expense is $3.79 M
What is BioXcel Therapeutics quarterly interest expense year-on-year change?
Over the past year, BTAI quarterly interest expense has changed by +$538.00 K (+16.54%)
What is BioXcel Therapeutics TTM interest expense?
The current TTM interest expense of BTAI is $14.53 M
What is the all time high TTM interest expense for BioXcel Therapeutics?
BioXcel Therapeutics all-time high TTM interest expense is $14.53 M
What is BioXcel Therapeutics TTM interest expense year-on-year change?
Over the past year, BTAI TTM interest expense has changed by +$1.73 M (+13.55%)